Skip to main content

Table 2 TFPI and TF tumor mRNA expression across clinicopathological breast cancer subtypes

From: Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF

 

mRNA expression (tumor)

Protein levels (plasma)

Characteristic

Groups

Total TFPI (α + β)

P

TFPIα

P

TFPIβ

P

TF

P

Total TFPI

P

Free TFPI

P

TF

P

T-status

T1

−0.146

0.054

−0.135

0.257

−0.084

0.201

−0.023

0.652

72.01

0.013

10.82

0.997

4.14

0.125

 

T2-T3

0.085

 

0.018

 

0.060

 

0.054

 

65.02

 

10.82

 

4.66

 

Grade

G1-G2

−0.022

0.850

−0.005

0.424

−0.033

0.743

0.271

0.003

71.04

0.082

10.66

0.682

4.63

0.557

 

G3

−0.045

 

−0.113

 

0.004

 

−0.229

 

66.12

 

10.97

 

4.14

 

N-status

Negative

−0.109

0.091

−0.136

0.127

−0.082

0.104

0.005

0.881

69.93

0.183

10.77

0.869

4.95

0.282

 

Positive

0.104

 

0.078

 

0.110

 

0.032

 

66.00

 

10.90

 

4.14

 

ER status

Positive

−0.067

0.317

−0.082

0.557

−0.056

0.183

0.001

0.784

69.42

0.240

10.91

0.671

4.42

0.409

PR status

Negative

0.076

 

0.011

 

0.123

 

0.057

 

65.44

 

10.52

 

5.28

 
 

Positive

−0.131

0.021

−0.145

0.075

−0.112

0.014

0.085

0.244

69.81

0.195

11.19

0.175

4.32

0.246

HER2-status

Negative

0.161

 

0.108

 

0.182

 

−0.127

 

65.92

 

10.08

 

5.04

 
 

Negative

−0.072

0.054

−0.101

0.073

−0.041

0.154

0.004

0.731

68.45

0.893

10.68

0.287

4.47

0.428

 

Positive

0.313

 

0.301

 

0.228

 

0.103

 

69.09

 

12.05

 

4.78

 

HR status

Yes

0.076

0.326

0.007

0.587

0.114

0.221

0.016

0.991

64.78

0.161

10.41

0.568

5.26

0.470

 

No

−0.066

 

−0.080

 

−0.052

 

0.014

 

69.57

 

10.94

 

4.47

 

Triple-negative status

Yes

−0.051

0.886

−0.110

0.718

0.041

0.635

−0.158

0.326

63.21

0.072

10.06

0.345

5.23

0.969

 

No

−0.029

 

−0.048

 

−0.027

 

0.055

 

69.73

 

10.99

 

4.57

 
  1. Median values for TFPI and TF mRNA expression in tumors and protein levels in plasma according to clinically defined groups. Corresponding P-values (unadjusted) are shown. Significant P-values in bold. TFPI, tissue factor pathway inhibitor; TF, tissue factor; HER2, human epidermal growth factor receptor 2.Abbreviations: T, tumor; G, grade; N, node; ER, estrogen receptor; PR, progesterone receptor; HR, hormone receptor.